Editor,-I read with interest the review article on the anaesthetic implications of thoracoscopic sympathectomy. 1 When endobronchial anaesthesia is used, carbon dioxide may be insufflated only initially into the ipsilateral pleural space to augment lung collapse. In contrast, when a tracheal tube is used, carbon dioxide is insufflated continuously until the end of surgery. The report assumes that hypoxic pulmonary vasoconstriction (HPV) fails during one-lung ventilation achieved by endobronchial anaesthesia, while it remains intact after tracheal intubation, as the ipsilateral lung is only partially collapsed. 1 This assumption is based on previous reports showing that when more than 70% of the lung is atelectatic, compensation by HPV appears to be ineffective. 2 The authors prefer tracheal intubation during thoracoscopy to endobronchial anaesthesia because of its simplicity, decreased cost, and improved oxygenation. To minimize the risk of inadvertent tension pneumothorax secondary to the continuous insufflation of carbon dioxide during tracheal anaesthesia, a pressure-limited, variable flow of carbon dioxide is recommended. 1 Experimental work in swine has shown that positive pressure insufflation during thoracoscopy results in significant haemodynamic compromise despite the use of selective lung ventilation: cardiac index, mean arterial pressure, and left ventricular stroke work index decreased, whereas pulmonary artery and central venous pressure increased at an insufflation pressure of 5 mm Hg or greater. 3 Thus, carbon dioxide insufflation into the closed chest cavity to a pressure as low as 5 mm Hg may create a physiological response very similar to that of a unilateral tension pneumothorax, 4 with a consequent haemodynamic instability secondary to decreased venous return and/or mediastinal shift.
Our anaesthetic technique during video-assisted thoracoscopy depends on double-lumen intubation which provides selective ventilation of the contralateral lung while allowing collapse of the ipsilateral lung without the need for carbon dioxide insufflation. Selective lung ventilation with 100% oxygen ensures adequate oxygenation throughout the procedure, as checked by continuous pulse oximetry. HPV is most active when 30-70% of the lung is hypoxic. 2 The original intrapulmonary shunt secondary to onelung collapse is about 40-50%, and is decreased to 20-30% by active HPV, 5 as well as by gravity, and collapse of the non-ventilated lung. Partial collapse of the lung on the thoracoscoped side occurs when air enters the pleural cavity. To augment collapse, the lumen of the double-lumen tube on the thoracoscoped side is opened to room air, while suction is intermittently applied. Since we have used selective contralateral lung ventilation, and avoided carbon dioxide insufflation into the ipsilateral pleural space, we have encountered no serious haemodynamic complications secondary to inadvertent tension pneumothorax.
A. BARAKA Department of Anesthesiology American University of Beirut
Beirut, Lebanon 1 The authors described the intranasal application of midazolam spray as a practicable method with high bioavailability in adult surgical patients. As the authors noted, intranasal spray application of midazolam could also be useful in children because of the described pharmacokinetic and pharmacodynamic advantages.
In particular, ambulatory anaesthesia in children requires rapid and effective premedication. Midazolam is well known for its anxiolytic, euphoric, amnesic and sedative qualities. Although various routes of administration in children have been approved for this drug, none is without problems.
After rectal application of midazolam 0.5 mg kg
91
, an effect typically appears within 15 min. However, 20% of children refuse this approach. 2 Sublingual administration of midazolam produces a faster effect, but requires a flavour corrigent because of its bitter taste. 3 Even then, acceptance is poor; the liquid is often expectorated, 4 and many children reject a second application. Additionally, the incidence of postoperative nausea and vomiting is highest after oral midazolam. 2 In the search for an alternative, it has been shown that nasal bolus administration of midazolam 0.2 mg kg 91 is an effective way to achieve rapid onset of sedation immediately before induction of anaesthesia in children. 5, 6 A higher dosage of midazolam 0.3 mg kg
did not increase the effects. 6 Intranasal midazolam achieves good conditions for the induction of anaesthesia with a maximum effect attained 5-10 min sooner than with rectal or oral application. The euphoric effect is more potent, and the sedative component is less than with rectal midazolam. 7 The main disadvantage of intranasal midazolam administration is a burning discomfort in the nasal mucosa and-similar to oral application-a bitter taste when midazolam runs into the pharynx. 8 In all these articles, nasal midazolam was administered as a bolus dose.
Because of the reported side effects, we introduced undiluted midazolam (15 mg in 3 ml, Dormicum, Hoffmann-La Roche, Grenzach-Wyhlen, Germany) via a nasal spray. Our pump spray applicator (Calmar-Albert dispensing systems, Hemer, Germany), normally used for rhinorrhoea, produces a fine, equally distributed aerosol of midazolam. Each application delivers a standard 0.12 ml, which corresponds to midazolam 0.6 mg. A new application set is used for each patient. The glass bottles and aerosol applicators can be sterilized after use.
For 1 year, children in our outpatient department aged 1-10 years have received midazolam 0.2 mg kg 91 via pump spray for premedication. We noticed a rapid onset of mild sedation, and euphoria 5-10 min after administration, which allowed a calm separation of the child from the parent. For safety reasons, pulse oximetry was always used after nasal midazolam administration. However, we did not observe any impairment of vital functions, as has been reported by other authors. [2] [3] [4] In our preliminary observations, children tolerated the spray application much better than the bolus administration. We observed fewer complaints of bitter taste and mucosal irritation. This leads to better acceptance and enhances the child's and the parent's trust in the anaesthetic procedure. On the basis of our experience, we recommend this new form of nasal midazolam administration via nasal spray. Editor,-Modern methods of cardiopulmonary resuscitation were introduced in 1960 after publication of the classic article by Kouwenhoven, Jude and Knickerbocker 1 on closed-chest cardiac massage. The CardioPump has been developed for resuscitation during cardiac arrest with the perceived advantage of increasing the forward flow of blood. We report a case in which the CardioPump was used, and a complication that may be associated with it and which was discovered only at postmortem examination.
A 60-year-old bricklayer with a basicervical fracture of the right hip underwent general anaesthesia for a right-sided AO dynamic hip screw. He was admitted to hospital 7 days before operation. Anaesthesia was induced with thiopentone 400-mg and fentanyl 75 g. A 3 in 1 block was performed with 30 ml bupivacaine 0.375% using a nerve stimulator. The patient was subsequently given atracurium 50 mg and intubated with a size 9.0 oral tracheal tube. Anaesthesia was maintained with isoflurane in oxygen and nitrous oxide, using intermittent positive pressure ventilation. Following manipulation of the injured leg, desaturation from an SpO 2 of 96% to 90% was noted, together with a fall in endtidal PCO 2 . The patient developed a tachycardia that proceeded to a electromechanical dissociation (EMD) cardiac arrest. Cardiopulmonary resuscitation (CPR) was started using the European Resuscitation Council Guidelines for an EMD arrest. 2 The Ambu CardioPump was used to aid resuscitation attempts, which were continued for 45 min with no effect. Resuscitation was then abandoned. At postmortem, a pulmonary embolism was found to be the cause of the cardiac arrest. Other findings included a haemoperitoneum associated with a 4 4 cm tear in the mesentery of the small bowel adjacent to the third part of the duodenum. Associated with this was a small traumatic laceration on the superior surface of the liver, adjacent to the insertion of the falciform ligament. Three fractured ribs (four, five and six) on the left side of the chest consistent with attempted resuscitation were also noted.
The CardioPump device consists of a horizontal handle, a piston and a suction cup. The radius of the suction cup is 6.5 cm and the height of the device is 13.5 cm.The device is placed in the midsternal position and 80-100 compressions per minute are performed at a pressure of 30-50 kg (as marked on the pump), equivalent to a chest excursion of 3.8-5.1 cm in standard CPR. The decompression phase produces a negative pressure of approximately 10 kg. The compression and decompression phases are performed in a ratio of 1:1. 3 Laceration of the liver and tearing of the mesentery of the small bowel adjacent to the third part of the duodenum can arise from standard CPR, especially if it is carried out incorrectly by the malpositioning of sternal compression. However, a new device was used in this case and its contribution to this complication is not known. The intra-abdominal trauma may be related to the higher pressures consistently produced in the compression phase with this device compared with standard CPR. We postulate an alternative theory. The active decompression phase may have contributed to the trauma as a considerable negative pressure is generated, and compared with standard CPR there is a greater change in intrathoracic and hence intra-abdominal pressure. We would also suggest that if this device were to be incorrectly positioned, that is below the sternal midpoint, the potential for intra-abdominal trauma would be increased.
The recent postgraduate resuscitation issue of the British Journal of Anaesthesia raises the question of the effectiveness of new resuscitation devices, asking if they are more beneficial than traditional CPR and if they carry added risks. 4 Only when these questions are answered can definitive recommendations ba made about the use of such devices.
There is little information available about complications associated with active compression-decompression CPR. One of the many reasons for carrying out postmortem examinations is to monitor the effectiveness and side effects of new medical and surgical therapies. A joint recommendation from the Royal Colleges of Surgeons, Physicians and Pathologists published in 1991 5 stated that there should be an increase in hospital postmortem examinations, in part to gather information on new treatments. This point has been reiterated in the National Confidential Enquiry into Perioperative Deaths. 6 We feel that nonsurvivors of CPR using these new methods of resuscitation should undergo postmortem examination to look for complications before such techniques are accepted as standard practice. 
Submandibular duct stone and difficult tracheal intubation
Editor,-A 54-year-old male presented for extracorporeal shock wave lithotripsy. Apart from renal calculi he was in good health (weight 64 kg, height 166 cm, BMI 23.23). He had no symptoms relating to the mouth, tongue or saliva. He had received two uneventful general anaesthetics in the preceding 3 weeks, neither of which needed tracheal intubation. There was no abnormality detected on physical examination: oral examination revealed a Mallampati class II intubation score. Anaesthesia was induced with propofol 150 mg, fentanyl 100 g and atracurium 50 mg. His lungs were ventilated easily with oxygen 33%, nitrous oxide 66% and sevoflurane 2%. On laryngoscopy, 3 min later, the tongue was found to be slightly deviated to the left and only the tip of the epiglottis was visualized. Manual ventilation of the lungs was resumed. After two unsuccessful attempts at intubation had been made, a size 4 laryngeal mask airway (LMA) was inserted. Surgery proceeded uneventfully and the LMA was removed after reversal of the neuromuscular blocking drug. Detailed examination of the mouth revealed a swelling at the base of the tongue on the right side. Postoperatively, the patient was referred to an otorhinolaryngologist, who suspected submandibular gland swelling because of stone formation in the submandibular duct. Subsequently, sialolithiasis of the submandibular duct was confirmed by radiography. Two, weeks later, the stone was removed under general anaesthesia; tracheal intubation was achieved using the McCoy laryngoscope and a gum elastic bougie.
Difficult laryngoscopy and intubation because of masses under the tongue such as a lingual thyroid, 1 sialadenitis 2 or sublingual haematoma 3 have been reported. Swelling of the tongue following general anaesthesia can also occur in association with angioedema. 4 It is unlikely that the swelling under the tongue in this patient was related to the recent episodes of general anaesthesia; both were atraumatic and neither required intubation. There was no evidence of sialadenitis or sublingual haematoma and angioedema usually causes generalized swelling of the tongue that becomes apparent within a few hours. 4 5 This case serves as a reminder that the anaesthetist should always make a thorough preoperative intra-oral inspection, especially where preoperative Mallampati is not class I.
T. MPHANZA Riyadh Saudi Arabia

Treatment of postoperative nausea and vomiting by acupressure
Editor,-The letter from Drs Harper and Barker 1 on post-operative nausea and vomiting poses the question, "Are there non-drug interventions that can help, such as reducing the length of the preoperative fast or the use of intra-operative fluids?"
A non-drug intervention that appears to have been overlooked is the use of acupressure by applying a stud on elasticated bands to the P6 (Neiguan) point on the wrists. Several studies have indicated that this inexpensive measure can reduce the incidence of postoperative nausea and vomiting 2 and also be of benefit in morning sickness 3 and chemotherapy-induced sickness. 4 Harper and Barker conclude by making a plea for more coordinated research to provide some answers. In view of the promising results already obtained, it would appear that P6 acupressure is worthy of further research. A study is in progress at my own hospital investigating this method as a means of reducing the incidence of nausea and vomiting associated with patientcontrolled analgesia. Editor,-We thank Dr Chow for his interes in our letter. We would support any research into means of reducing postoperative nausea and vomiting (PONV) to a minimum. However, acupressure, like other single-agent regimens investigated, has been only partially effective in reducing the incidence of PONV. We would still feel that future research should be directed at treating those patients at risk of PONV, as ascertained by a scoring system, with one, two or three combined active treatments. This could be one or two antiemetic agents with different sites of action plus non-drug intervention such as acupressure or intraoperative fluids. Perhaps in this way, the incidence of PONV can be reduced to minimal levels.
A. E. CHOW
J. P. BARKER C.M. HARPER Barnet General Hospital
Barnet, Herts
Local analgesia in early and late stages of labour
Editor,-As an obstetrician, I read with interest the article by Capogna and colleagues. 1 The authors measured the minimum local analgesic concentration (MLAC) of bupivacaine in both the early and late stages of labour. They conclude that advancing labour requires an increased concentration of extradural bupivacaine for pain relief. Regional anaesthesia has a direct influence over obstetric practice in terms of operative delivery and progress of labour, and research into optimal intrapartum analgesia is always of interest. Research like this is lacking. 2 From an obstetric point of view, there are several factors of which anaesthetists should be aware when considering this study. Although the two groups were well matched with respect to maternal characteristics, it would have been helpful to have had more intrapartum details. Labours induced with prostaglandins are longer than spontaneous labours, and an induction of labour with prostaglandins or oxytocin can cause uterine activity in the absence of progressive cervical dilatation. Were inductions of labour included in this sample? We are told that 20 out of 30 women had oxytocin. Was the oxytocin given before the visual analogue profile scores (VAPS)? It would be wise to consider these women as a separate group, as the use of oxytocin suggests that labour was prolonged because of incoordinate uterine activity, cephalopelvic disproportion or induction. Either way, labours with oxytocin are abnormal and should be considered separately from spontaneous labours, which on average will be shorter in duration and hence have different, possibly lower,VAPS.
Finally, I disagree with combining data from nulliparous and multiparous women, as these two groups have very different intrapartum profiles. Nulliparous women are prone to incoordinate uterine activity at any stage of labour and require oxytocin to correct this. As a result labour can be longer. This is rarely the case with multiparous women.
Cervical dilatation is only one of many important intrapartum findings used to assess the stage of labour. Not only the degree of cervical dilatation, but also the rate of dilatation and foetal head descent should be considered, together with the women's parity, the quality and frequency of the uterine contractions and the size of the foetus. Editor,-We thank Dr Nunns for his comments on our study. We are aware of the differences between spontaneous and induced labours and therefore excluded induced labours from our sample. In some cases, oxytocin was given to the mothers, always after extradural analgesia, according to the obstetrician's wishes. However, the number of women who received oxytocin was not statistically different between the two groups. I agree with the observation concerning the different intrapartum profiles of nulliparous and multiparous women. These two groups represent different 'species' of parturient, and I believe any study that seeks to minimize independent variables should exclude one or other group. In addition, all studies in obstetric unaesthesia should compare women at the same stage of labour.
D. NUNNS
However, in this study we did not evaluate the effect of MLAC on the duration or outcome of labour, but only the efficacy of the solution tested for a definite period (our study protocol observed analgesic efficacy for a maximum of 1 h). For this reason, we decided that a mixed group of nulliparous and multiparous women was acceptable.
In the study, we showed that the MLAC of bupivacaine increased with advancing labour. That means that, when low concentrations of local anaesthetic are used, the first dose of local anaesthetic may need to be increased if labour has already advanced.
G. CAPOGNA Fatebenefratelli General Hospital Rome
A guide for tube exchange using a fibrescope and the plastic sheath of a guidewire in small children Editor,-When managing a difficult airway, occasionally there is a need to replace a tracheal tube. For example, one may have to change a tracheal tube for a larger one after intubation through a laryngeal mask airway (LMA). 1 2 But, in small children, tube exchange techniques ore not readily available.
As a guide for tracheal tube exchange, we used the plastic sheath of a guidewire within a central venous line set (B. Brown Medical, Bethlehem, PA). The sheath is a hollow plastic tube and has an internal diameter of about 3 mm and is about 65 cm long. It is supplied in a circular form ( fig. 1A ) and can be uncoiled in a halfcircle shape ( fig. IB, C) because of its plastic character. One may use any kind of plastic sheath that is a little malleable, has sufficient length, an inner diameter large enough to accommodate a fibrescope, and an outer diameter small enough to pass through a tracheal tube. The length of the sheath should be adjusted to only a few cm shorter than the working length of a fibrescope (the length of an Olympus LF-P is 60 cm).The square-cut leading edge of the sheath may be blocked half way on the curved inner surface of the tracheal tube, so we suggest making a bevel of about 45Њ on the convex side of its tip. The length of the tracheal tube to be changed should be pre-marked on the shaft of the sheath.
We have exchanged a tracheal tube for a larger one after intubation through an LMA in two small children. One was a 4-year-old, 16-kg boy with Treacher-Collins syndrome, in whom a tracheal tube of 4.5 mm internal diameter was exchanged for a 5.5 mm tube. The other was a 5-year-old, 7.7-kg boy with Goldenhar's syndrome, in whom a 4 mm tracheal tube was exchanged for a 4.5 mm tube. To prevent potential mucosal damage from the sharp tip of the sheath, we inserted an ultrathin fibrescope (Olympus LF-P, outer diameter 2.2 mm) through the sheath beforehand ( fig. 1B) . We advanced the, fibrescope into the trachea ahead of the sheath, with its proximal end abutting the fibrescope handle. We maintained the fibrescope in situ to confirm its intratracheal location while removing the tracheal tube and LMA from the mouth. While holding the sheath, we removed the fibrescope, off-loaded the tracheal tube and LMA, reloaded a larger tracheal tube over the sheath, reinserted the fibrescope into the sheath, and finally railroaded the larger one over the sheath to the desired depth. This method may prevent inadvertent extubation by continuously confirming the intratracheal location during the critical period of removing or inserting a tracheal tube over a tube exchanger, and can simultaneously adjust its depth. Similar techniques have been reported, 3 4 but these were used in adults. An alternative technique is also available: one can cut away the former tracheal tube as described by Gatell and colleagues. 5 Then it is not necessary to pull out the fibrescope during removal of the first-tracheal tube, but one would have to load a new tracheal tube before the exchange. Additionally, the presence of a sheath can protect the expensive fibrescope from damage by a pair of scissors or scalpel.
The presence of a fibrescope within the sheath can stabilize and strengthen it and may reduce potential mucosal injury by minimizing contact of the tip with tracheal mucosa. Additionally, use of a fibrescope can prevent tracheobronchial rupture, which has been reported with the blind use of a tube exchanger. 6 The sheath can be used only for 4.0 mm tracheal tubes or larger. It also can be connected to an oxygen source or to a capnograph through an appropriate adaptor. For example, a 15 mm connector for a 2.0 mm tracheal tube can fit snugly into the sheath, or it may be wedged into the distal end of a 3.5 mm tracheal tube cut at the shaft ( fig. 1C) .
It is preferable if a tube exchanger, which can accommodate a, fibrescope and has a blunt tip, is made of clear material to allow surrounding tissues to be seen. Additionally, if it has an inflatable balloon at the tip, just like a cuffed tracheal tube, it may reduce mucosal injury and anchor the tube exchanger at the subglottic area while the tube is being exchanged in young children.
J-H. BAHKFI C-W. JUNG S-D. KIM Department of Anesthesiology Seoul National University Hospital
Seoul, Korea
Sevoflurane for difficult tracheal intubation
Editor,-We read with interest the report and subsequent correspondence on the use of sevoflurane in patients with difficult airways. [1] [2] [3] These reports describe the use of a stepwise inhalation induction technique. While the use of such a cautious approach would seem prudent in patients with anticipated airway problems, the evidence suggests that this technique is associated with a higher incidence of complications. 4 A stepwise increase of inspired sevoflurane concentration is not only slower but also prolongs the second stage, resulting in an unacceptably high level of excitement and coughing. We would suggest that the technique of choice in patients with a difficult airway is to breathe sevoflurane 8% from the start, as this has a lower incidence of cough and excitement (2% and 10% respectively) 5 compared with a stepwise technique (12% and 31% respectively). 4 Apnoea is relatively uncommon with this technique (16%) and typically short-lived, the average time from loss of consciousness until resumption of spontaneous breathing being 10 s. 5 As the addition of nitrous oxide has little effect on the speed or quality of inhalation induction with sevoflurane, 6 we would recommend that in patients with difficult airways, sevoflurane is administered in oxygen 100%.
Sevoflurane alone can be used to facilitate tracheal intubation. We have found intubation conditions to be satisfactory at about 4 min in unpremedicated adults and at about 2.5 min in children. An alternative approach to facilitate tracheal intubation after a sevoflurane induction is to give a neuromuscular blocking agent once the vocal cords have been clearly visualized. Editor-, The authors refer to two papers 1 2 which, they suggest, recommend sevoflurane 8% in oxygen as the technique of choice in patients with a difficult airway.
A.J. THWAITES I. SMITH
Yurino and Kimura 1 report a 31.25% incidence of movements during inhalational induction with stepwise increments of sevoflurane 0.5% every third to fourth breath, compared with an incidence of 6.25% in a vital capacity induction of sevoflurane 4.5% in nitrous oxide-oxygen. The incidence of coughing was 6.25% in the vital capacity induction compared with 12.5% in the stepwise technique, but I would suggest that their stepwise technique is in no way comparable to the one described by Mostafa and Atherton, and myself. 3 4 The technique described in my report involves more rapid increments of at least 1% or more after pre-oxygenation, depending on the maintenance of spontaneous ventilation and control of the airway. It is worth noting that the original authors describe the coughing and movements as being of mild intensity. 1 Thwaites, Edmends and Smith 2 compared inhalational induction using sevoflurane 8% in nitrous oxide-oxygen to i.v. propofol (n : 102), and reported purposeful movement in three patients in the propofol group compared with five in the sevoflurane group. Although the incidence of coughing was only 2% during inhalational induction, the same authors also reported an 8% incidence of coughing during the transition from induction to maintenance of anaesthesia.
I have not found coughing and excitement to be a major problem in an ongoing audit of a predominantly Asian group of patients with head and neck tumours. A 16% incidence of apnoea in the use of a sevoflurane 8% induction cannot be ignored.
Indeed, in one patient with tonsillar carcinoma who underwent sevoflurane 8% vital capacity Induction in our hospital, the duration of apnoea would have led to hypoxia if assisted ventilation had been impossible. Although the use of sevoflurane 8% results in faster onset of anaesthesia, the advantage of gas induction is not speed but safety. 5 A stepwise induction enables the experienced anaesthetist to assess airway patency and the ability to assist ventilation. The low blood-gas solubility of the agent allows the option to abort before an unnecessarily deep plane of anaesthesia is reached.
In conclusion, before inhalational induction with sevoflurane 8% can be favoured over a stepwise technique, the outcome from the management of actually difficult cases needs to be reported. Editor,-The figures quoted for cough and excitement with a high-dose technique of inhalation induction with sevoflurane are 2% and 10% respectively. 1 However, other research has reported complication rates of 25% for coughing 2 and 38% for excitement 3 when using sevoflurane 8% from the outset. These are higher than the quoted rates for a step wise approach (12% and 31% respectively). 4 5 Complication rates seem to be lower if a vital capacity technique is used, but such a technique would not be easy to use in someone with a difficult airway.
P.C. IP-YAM
Coughing may also be linked to how quickly a concentration of sevoflurane 8% is reached. 1 The theory is that if the anaesthetic circuit is pre-primed with sevoflurane 8%, this leads to an abrupt increase in inspired vapour concentration when the facemask is applied. This is irritant and leads to coughing. The alternativepre-oxygenating the patient and then adding the sevoflurane 8% to the flow -allows dilution of the agent and a more gradual increase in inspired vapour concentration. This is better tolerated by the patient (and is more akin to the stepwise approach).
More serious complications, such as laryngospasm, have been reported in patients in whom anaesthesia was induced with sevoflurane 8%. 6 Severe hypoventilation has also been noted to occur in children. 6 There are several reports of profound bradycardia in children during induction of anaesthesia with sevoflurane using the high-concentration approach. 7 These are reasons for adopting a more cautious approach, especially with a difficult airway.
Finally, 29% of patients in whom anaesthesia was induced with sevoflurane recalled an unpleasant smell afterwards. 1 Half of these described the whole induction experience as unpleasant, compared with none in a propofol control group. Patient comfort is surely the most compelling reason for an incremental approach; the stepwise approach allows patients to become familiar with the smell in a gradual, controlled manner rather than being suddenly exposed to the full pungency of the vapour. They remain calm and confident in their anaesthetist. There is still rapid loss of consciousness, because of the low blood gas solubility coefficient of sevoflurane, following which rapid progression to maximum concentration minimizes the excitement phase.
P. BOARD
Newcastle-upon-Tyne 
Early vs late tracheal extubation after CABG surgery
Editor,-The recent paper by Berry and colleagues highlights the important issue of the safety of early tracheal extubation after coronary artery bypass graft (CABG) surgery. 1 A crucial question is whether the potentially adverse effects of tracheal extubation on myocardial oxygen balance are significant when the heart is recovering from the ischaemic insult associated with proximal aortic crossclamping. Early extubation after CABG surgery is safe only if it does not exacerbate perioperative cardiac muscle injury.
The regulatory cardiac contractile protein, cardiac troponin I (cTnI), is present exclusively in cardiac muscle tissue and is an accurate biochemical marker of perioperative cardiac muscle injury. [2] [3] [4] [5] In a recent study comparing Holler continuous EGG ST segment analysis with serum cTnI concentrations during the postoperative period after CABG surgery, we found that early postoperative electrocardiographic myocardial ischaemia was associated with elevated postoperative serum cTnI concentrations. 6 Data from three out of 30 patients in this study indicated that electrocardiographic myocardial ischaemia within the first 8 h after the end of cardiopulmonary bypass was precipitated or exacerbated by withdrawing sedation in preparation for tracheal extubation. Although for these three patients the electrocardiographie myocardial ischaemia was immediately resolved by resedation and mechanical ventilation, postoperative serum cTnI concentrations were elevated. Data from the study by Berry and colleagues 1 show that a small but significant proportion of patients (10%) who meet standard early extubation criteria have a high myocardial ischaemic burden (915 min h 91 ) during the early postoperative period. As the incidence of myocardial ischaemia falls exponentially with time during the early postoperative period, 7 the earlier that extubation is performed, the greater is the chance that it will occur simultaneously with electrocardiographic myocardial ischaemia.
Therefore for patients who fulfil the criteria for early extubation after CABG surgery, during weaning from postoperative sedation, the continuous EGG ST segment monitor (now incorporated into most ICU or operating theatre monitors) should be closely observed. If myocardial ischaemia is present, extubation should be postponed until these EGG ST segment abnormalities have been resolved. Although in the study by Berry and colleagues 1 19 out of 359 episodes of electrocardiographic myocardial ischaemia occurred during the extubation period, it is not clear first, in how many patients this occurred or second, whether extubation precipitated or exacerbated myocardial ischaemia.
D. A. TUPPER-CAREY
Department of Anaesthesia Royal London Hospital London
Editor,-Thank you for the opportunity to reply to the comments of Dr Tupper-Carey. As he suggests, it is important to assess the impact of any adverse haemodynamic changes associated with early extubation on the total ischaemic load experienced. If the "extubation period" is defined as 30 min either side of tracheal tube removal, then in our study, six patients in the early extubation group and two in the late extubation group experienced ischaemic episodes in this period. It is clear from previous studies that the incidence of electrocardiographic ischaemia is greatest in the 8 h after surgery and declines with time. Our early extubation group were allowed to waken as soon as they returned from the operating theatre and the average time of extubation was almost 11 h earlier than in the late group. Nevertheless, we found no difference in the total incidence or severity of postoperative ischaemia. Review of our haemodynamic data demonstrated that the major haemodynamic changes occur within the first 30 min after discontinuing volatile anaesthetics, and the haemodynamic effects of extubation are mild and shortlived. Extubation itself did not appear to initiate or exacerbate ECG ischaemia. Dr Tupper-Carey has observed that patients with early postoperative ST-segment change have elevated levels of troponin I. Troponin I is cardiospecific and peak levels are seen 1 day after the onset of myocardial necrosis, but elevated levels persist for 3-4 days. Patients undergoing aortic crossclamping may suffer significant degrees of myocardial ischaemia and necrosis despite all attempts at cardioprotection.This intraoperative myocardial insult may lead to both troponin I release and postoperative myocardial ECG ischaemia in those patients suffering the severest insult.
We do not dispute the importance of these changes. However, it is clear from our study that the postoperative management strategy of early extubation does not influence their frequency or severity.
P. D. BERRY Department of Anesthesia
University of California San Francisco USA 
Venous air embolism and PEEP: a clinical research blind-spot
Editor,-The recent clinical study by Giebler and colleagues on 89 patients undergoing neurosurgery in the sitting position reported that the use of 10 cm H 2 O positive end-expiratory pressure (PEEP) did not reduce their overall 26% incidence of venous air embolism (VAE).
1
While not necessarily disagreeing with their conclusion that the use of PEEP "cannot be recommended", I believe they misinterpreted one of the findings of Meyer and colleagues, 2 who reported a zero incidence of VAE in 30 children being managed with PEEP and a MAST suit, compared with a 26% incidence in a control group. Though the "filling pressures" in both the Meyer and the Giebler studies "did not differ", it should be noted that, in the Meyer study, the reported right atrial pressures would have been sufficient to distend the venous system of many of the sitting children to a level approximating the level of the jugular bulb. The protective mechanism of a MAST suit and PEEP could not be translated to adult patients, as it is not clinically feasible to maintain the venous pressure at equivalent high levels. and even the internal jugular veins, 4 5 and to reduce the risk of a massive life-threatening embolism. 4 I believe that greater emphasis should be placed on the need to maintain a raised central venous pressure, whether it be by MAST suit application, transfusion or a combination of these.
In our hospital, neurouurgery with the patient in the sitting position has not been performed for many years. For clarification of several issues, therefore, I seek advice from centres where such surgery is performed. Does maintaining the central venous pressure at, for example, 10 mm Hg using a transducer zeroed at the level of the upper part of the right atrium, result in embolized air collecting or 'pooling' upwards in the superior vena cava, either temporarily or in part, as it does in a model 3 and in sheep?
Editor,-We appreciate Dr Pfitzner's letter in response to our article 1 and the interest in our clinical research. Dr Pfitzner feels that we may have misinterpreted the findings of Meyer and colleagues who reported a zero incidence of venous air embolism (VAE) in children managed with both PEEP and a MAST suit, compared with a 26% incidence in a control group. 2 Obviously, the distance between the right heart and jugular bulb or brain surface is much smaller in young children than in adults. As Meyer and colleagues reported an average central venous pressure of 11 mm Hg in children in the sitting position, this pressure may have been sufficient to minimize air entry and clinically relevant VAE in children, but is unlikely to be sufficiently high in adults, as indicated by the results of our study. 1 Accordingly, children are like neither adults nor sheep.
We rarely use anti-gravity suits, because the increase in filling pressures has been reported as only transient. 3 We care for many adults with heart disease and try to minimize cardiac volume overload during surgery. Whether PEEP at levels markedly in excess of 10 cm H 2 O may be effective in decreasing the incidence of VAE and yet not impair cardiovascular performance is beyond the scope of our investigation. This is unlikely, however, as although PEEP increases venous pressure relative to atmosphere, it also decreases cardiac transmural filling pressures and thus cardiac filling and output. 4 Whether an increased venous pressure will, in theory, serve to promote the temporary collection of embolized air in the superior vena cava and even in the internal jugular veins, as speculated by Pfitzner and colleagues, 5 6 and reduce the risk of massive lifethreatening embolism, is certainly interesting. To our knowledge, clinical data on this topic are not available. However, Pfitzner 5 himself could not demonstrate clear evidence that blood volume or PEEP influenced the yield of air at aspiration.
Furthermore, from a clinical viewpoint, this hypothesis can hardly be tested in a quantitative fashion because a Doppler probe is placed over the heart but the superior vena cava cannot reliably be visualized by transoesophageal echocardiography. Accordingly, data collection from sitting sheep may be the only way to address Dr Pfitzner's hypothesis, but may be of questionable clinical relevance! Therefore, we cannot provide an answer to Dr Pfitzner's question, as to whether a certain central venous pressure results in "trapping" of embolized air in the superior vena cava or, of even greater interest, in a step pressure gradient along the superior vena cava in the vertical position, allowing a potential diagnosis of VAE. The answer to this question may also depend on the presence and competence of venous valves in the jugular venous system, which in certain individuals may or may not be functional. 7 Indeed, differences in the venous valve system may benefit sheep but not human adults during VAE.
J. PETERS R. GIEBLER Essen, Germany
Walking extradurals
Editor-Thank you for the opportunity to reply to the letter published in the May issue of the British Journal of Anaesthesia. 1 We are sorry that our title and editorial confused the authors. The inverted commas around "walking extradural" were meant to convey the fact that although such a regional blockade is commonly called an epidural it often involves a spinal component.
The use of combined spinal epidural analgesia in labour is controversial. Several authors from various centres including one from Queen Charlotte's Hospital itself 2 have questioned its routine use in labour.
Our editorial attempted to explore the possibility of ambulation in labour, its safety, the techniques available and possible effects on the mode of delivery. Few studies involving low dose regional blockade in labour have described accurately either the ability to walk or actual rates of ambulation. Low rates of ambulation and the use of higher concentrations of local anaesthetic solution in late labour may explain the inability of some studies to demonstrate any difference in obstetric outcome. We accept that the lower the total dose of local anaesthetic administered into the epidural space, the lower will be the resultant motor blockade. A small dose of local anaesthetic administered intrathecally with combined spinal epidural analgesia in labour has a very rapid onset for the anatomical reasons given. However, there is little evidence that this influences dose requirement and subsequent motor block several hours after the initial dose.
We accept that the combined spinal-extradural technique is popular and useful but we hoped that our editorial gave a balanced, cautious assessment of its potential in obstetrics.
We discussed the first use of the epidural catheter after a combined spinal-extradural. In this situation, the first dose is the test dose and should be given by someone able to identify and treat the consequences of intravenous and intrathecal placement of the catheter. Our use of the term "appropriately trained person" was intentional and not a substitution of the word "anaesthetist". It is entirely possible that a midwife could be trained to give this first dose provided that he or she is also trained to recognise the consequences of inadvertent intrathecal administration and that an anaesthetist is immediately available. The first dose should not be given by a patient-controlled epidural analgesia device in the absence of an appropriately qualified individual.
We did not advocate the use of a test dose of high concentration lignocaine or bupivacaine. Indeed, in our discussion on proprioception, we suggested that this was undesirable. We do not recommend flushing the epidural catheter immediately after placing it in the epidural space.
We did not say there was an excess incidence of meningitis after combined spinal-extradural but stated that an excess would limit the use of this technique. Penetrating the dura represents an even greater compromise of host defences than merely penetrating the ligamentum flavum. We do believe it is important to pay scrupulous attention to aseptic technique and the avoidance of chemical contamination when giving intrathecal drugs. 3 We accept that the use of the phrase "provides evidence for the inherent safety of the technique" was open to misinterpretation.
We wholeheartedly agree that the provision of safe, efficacious analgesia in labour should be a health care priority. We believe in a woman-centred approach based on informed choices of analgesia.
Further work is necessary to establish the benefits of ambulation in labour and to justify the routine use of additional interventions such as dural puncture; recently, disadvantages of subarachnoid opioid analgesia such as delayed gastric emptying 4 and an association with transient uterine hypertonus and resultant fetal distress, have been reported. 5 
